Lord Abbett Developing Growth Fund Class F3 LOGWX

Morningstar Medalist Rating
  • NAV / 1-Day Return$37.23  /  +2.00%
  • Fund Size$1.8B
  • Adjusted Expense Ratio0.600%
  • Net Expense Ratio0.590%
  • Fee Level: DistributionLow
  • Share Class TypeNo Load
  • Morningstar CategorySmall Growth
  • Equity Style Box (Funds)Small Growth
  • Minimum Initial Investment$0
  • Investment StatusOpen
  • TTM Yield< 0.01%
  • Turnover Ratio110%

Morningstar’s Analysis LOGWX

Will LOGWX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

An experienced small-cap team employs a volatile, momentum-driven approach.

Analyst Drew Carter

Drew Carter

Analyst

Summary

Lord Abbett Developing Growth’s aggressive, momentum-driven approach can swing performance to extremes, but it has rewarded patient, long-term investors.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LOGWX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings22.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Guardant Health Inc

3.0962M
Healthcare

Navan Inc Ordinary Shares - Class A

2.7755M
Technology

JFrog Ltd Ordinary Shares

2.6753M
Technology

10x Genomics Inc Ordinary Shares - Class A

2.1944M
Healthcare

DigitalOcean Holdings Inc

1.9940M
Technology

Twist Bioscience Corp

1.9840M
Healthcare

SiTime Corp Ordinary Shares

1.9539M
Technology

Madrigal Pharmaceuticals Inc

1.8537M
Healthcare

Imax Corp

1.8036M
Communication Services

Cogent Biosciences Inc

1.7836M
Healthcare

Sponsor Center